EFEK PEMBERIAN MATRIX METALLOPROTEINASE-9 ( MMP- 9) RNA INTERFERENCE TERHADAP EKSPRESI MMP- 9 PADA KULTUR SEL ENDOTEL VASKULAR

Authors

  • Lely Retno Wulandari Laboratorium Ilmu Penyakit Mata Fakultas Kedokteran Universitas Brawijaya/ RSU dr. Saiful Anwar Malang
  • Hidayat Suyuti Laboratorium Biokimia Biomolekuler Fakultas Kedokteran Universitas Brawijaya
  • Nadia Artha Dewi Laboratorium Ilmu Penyakit Mata Fakultas Kedokteran Universitas Brawijaya/ RSU dr. Saiful Anwar Malang
  • Safaruddin Refa Laboratorium Ilmu Penyakit Mata Fakultas Kedokteran Universitas Brawijaya/ RSU dr. Saiful Anwar Malang

DOI:

https://doi.org/10.21776/ub.jkb.2006.022.02.1

Abstract

ABSTRACT Retinal neovascularization is the main problem that causes blindness in many types of eye desease. Neovascularization occurs in ischemic retina, and several important mediators that induce neovascularization is secreted by the surrounding cell and endothelial cell vessels. Matrix metalloproteinase-9 is an enzyme secreted by endothelial cell vessels and plays an important role in the pathogenesis of retinal induce neovascularization. Vascular endothelial cells were cultured and transfected with Matrix Metalloproteinase -9 RNA interference in two doses (100nM or 200nM) and the cells were taken at 24,  48  and  72  hours.  The  expression  of  Matrix  Metalloproteinase  -9  protein  levels  were  examined  by immunocytochemistry, and compared with control group. The data were analyzed with factorial anova. Statistical analysis showed that transfection with different doses of MMP-9 RNAi gave a significant different effect on MMP-9 expression (p-value < 0.05), while exposure time did not give significant difference (p-value < 0.05). This in-vitro study indicated that transfection  of  MMP-9  RNAi  with  dose  200nM  reduced the  expression  of  MMP-9  by  50%  compared  to  the  control. Because exposure time was not significant, the lowest expression of MMP-9 can be achieved by transfecting MMP-9 RNAi 200nM for 24 hours. This is the first study that demonstrates the effectiveness of RNA interference mediated targeting  of MMP-9 to reduce the MMP-9 expression in vascular endothelial cell lines Key Words  : Matrix Metalloproteinase -9 - RNA interference - vascular endothelial cell lines.

Downloads

Download data is not yet available.

References

DAFTAR KEPUSTAKAAN

Salzmann J, Limb A, Khaw P. Matrix metalloproteinases and their Natural Inhibitors in Fibrovascular Membranes of Proliferative Diabetic Retinopathy. Br J Ophthalmology 2002; 84:1091-1096

Lambert V, Munaut C, Jost M. Matrix Metalloproteinase-9 Contributes to Choroidal Neovascularization. American Journal of Pathology 2002;161:1247-1253

Das A, McLamore A, Song W. Retinal Neovascularization is Supressed with a Matrix metalloproteinase Inhibitor. Archives of Ophthalmology.1999;117:498-503

Pepper M. Role of the Matrix metalloproteinase and Plasminogen Activator-Plasmin Systems in Angiogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:1104

Milhavet O, Gary D, Mattson M. RNA Interference in Biology and Medicine. Pharmacological Reviews.2003;55: 629-648

Edelman JL, Lutz D, Castro MR. Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood

retinal and blood aqueous barrier breakdown. Exp Eye Research.2005;80(2):249-258.

Stetler-Stevenson WG. Matrix metalloproteinase in Angiogenesis: a moving target for Therapeutic Intervention. Journal of Clinical Investigation. 1999;103:1237-1241

Ehelrs N. Metalloproteinases. Department of Ophthalmology University of the Witwatersrand. January 2001 Available

on http://www.health.wits.ac.za/ophthalmology/opjan01.htm

Sethi. Matrix metalloproteinase Biology applied to Vitreoretinal Disorders. Br J Ophthalmology 2000;84:654-666

Downloads

Published

2013-03-25

Issue

Section

Research Article